Array-based comparative genomic hybridization analysis reveals chromosomal copy number aberrations associated with clinical outcome in canine diffuse large B-cell lymphoma.
Canine Diffuse Large B-cell Lymphoma (cDLBCL) is an aggressive cancer with variable clinical response. Despite recent attempts by gene expression profiling to identify the dog as a potential animal model for human DLBCL, this tumor remains biologically heterogeneous with no prognostic biomarkers to...
Guardado en:
Autores principales: | Arianna Aricò, Serena Ferraresso, Silvia Bresolin, Laura Marconato, Stefano Comazzi, Geertruy Te Kronnie, Luca Aresu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c69288cf336e43e3a27944a281b0616b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Epigenetic silencing of TFPI-2 in canine diffuse large B-cell lymphoma.
por: Serena Ferraresso, et al.
Publicado: (2014) -
Sleeping Beauty: Anesthesia May Promote Relapse in Dogs With Diffuse Large B-Cell Lymphoma in Complete Remission After Chemo-Immunotherapy
por: Eugenio Faroni, et al.
Publicado: (2021) -
The association between DNA copy number aberrations at chromosome 5q22 and gastric cancer.
por: Pei-Chien Tsai, et al.
Publicado: (2014) -
Computed tomography may detect liver infiltration of canine diffuse hepatic lymphoma
por: Toshiyuki Tanaka, et al.
Publicado: (2021) -
Generation of a canine anti-canine CD20 antibody for canine lymphoma treatment
por: Takuya Mizuno, et al.
Publicado: (2020)